SELLAS Life Sciences Group (SLS) Operating Income: 2011-2023
Historic Operating Income for SELLAS Life Sciences Group (SLS) over the last 8 years, with Dec 2023 value amounting to -$37.9 million.
- SELLAS Life Sciences Group's Operating Income rose 13.43% to -$8.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$37.9 million, marking a year-over-year increase of 9.73%. This contributed to the annual value of -$37.9 million for FY2023, which is 9.73% up from last year.
- As of FY2023, SELLAS Life Sciences Group's Operating Income stood at -$37.9 million, which was up 9.73% from -$42.0 million recorded in FY2022.
- In the past 5 years, SELLAS Life Sciences Group's Operating Income registered a high of -$17.0 million during FY2020, and its lowest value of -$42.0 million during FY2022.
- Its 3-year average for Operating Income is -$35.0 million, with a median of -$37.9 million in 2023.
- In the last 5 years, SELLAS Life Sciences Group's Operating Income climbed by 15.26% in 2020 and then plummeted by 65.85% in 2022.
- Yearly analysis of 5 years shows SELLAS Life Sciences Group's Operating Income stood at -$20.0 million in 2019, then climbed by 15.26% to -$17.0 million in 2020, then plummeted by 48.95% to -$25.3 million in 2021, then crashed by 65.85% to -$42.0 million in 2022, then grew by 9.73% to -$37.9 million in 2023.